ContraVir Pharmaceuticals Inc. | Balance Sheet
Fiscal year is July-June. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
86.70
1,817.80
4,563.20
7,403.90
12,982.70
2,832.40
Other Current Assets
-
164.40
681.20
491.00
210.20
135.60
Total Current Assets
86.70
1,982.20
5,244.40
7,895.00
13,192.90
2,968
Net Property, Plant & Equipment
-
14.50
81.40
80.80
67.60
32.40
Intangible Assets
-
-
-
5,060.90
5,060.90
5,060.90
Other Assets
-
4.20
51.30
70.00
63.20
127.80
Total Assets
86.70
2,000.90
5,377.20
13,106.70
18,384.60
8,189.20
ST Debt & Current Portion LT Debt
100.30
-
-
10.40
-
Accounts Payable
3.60
-
-
-
1,626.80
Other Current Liabilities
123.30
458.70
1,938.10
5,073.10
1,318.10
Total Current Liabilities
227.20
458.70
1,938.10
5,083.50
2,944.90
Provision for Risks & Charges
-
-
-
3,320.00
3,410.00
Deferred Taxes
-
-
-
1,269.60
1,269.60
Other Liabilities
-
4,475.40
-
2,116.00
1,702.20
Total Liabilities
227.20
4,934.10
1,938.10
11,789.10
9,326.70
Common Equity (Total)
140.50
2,933.20
10,260.90
12,382.40
8,017.70
Total Shareholders' Equity
140.50
2,933.20
3,439.10
1,317.60
9,057.90
Total Equity
140.50
2,933.20
3,439.10
1,317.60
9,057.90
Liabilities & Shareholders' Equity
86.70
2,000.90
5,377.20
13,106.70
18,384.60
Preferred Stock (Carrying Value)
-
-
13,700.00
13,700.00
1,040.10
About ContraVir Pharmaceuticals
View Profile
